Westside Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $63.5K | Hold |
702
| – | – | 0.01% | 525 |
|
|
2026
Q1 | $56.3K | Hold |
702
| – | – | 0.01% | 532 |
|
|
2025
Q4 | $59.9K | Buy |
702
+6
| +0.9% | +$492 | 0.01% | 494 |
|
|
2025
Q3 | $54K | Sell |
696
-600
| -46% | -$46.9K | 0.01% | 516 |
|
|
2025
Q2 | $101K | Buy |
1,296
+96
| +8% | +$7.16K | 0.02% | 344 |
|
|
2025
Q1 | $87K | Hold |
1,200
| – | – | 0.02% | 325 |
|
|
2024
Q4 | $88.8K | Hold |
1,200
| – | – | 0.02% | 322 |
|
|
2024
Q3 | $79.2K | Hold |
1,200
| – | – | 0.02% | 339 |
|
|
2024
Q2 | $111K | Hold |
1,200
| – | – | 0.03% | 294 |
|
|
2024
Q1 | $115K | Hold |
1,200
| – | – | 0.03% | 281 |
|
|
2023
Q4 | $91.5K | Hold |
1,200
| – | – | 0.02% | 289 |
|
|
2023
Q3 | $83.1K | Hold |
1,200
| – | – | 0.02% | 292 |
|
|
2023
Q2 | $113K | Hold |
1,200
| – | – | 0.03% | 260 |
|
|
2023
Q1 | $99.3K | Hold |
1,200
| – | – | 0.03% | 275 |
|
|
2022
Q4 | $89 | Hold |
1,200
| – | – | ﹤0.01% | 366 |
|
|
2022
Q3 | $99 | Hold |
1,200
| – | – | ﹤0.01% | 358 |
|
|
2022
Q2 | $114 | Hold |
1,200
| – | – | ﹤0.01% | 340 |
|
|
2022
Q1 | $141 | Hold |
1,200
| – | – | ﹤0.01% | 341 |
|
|
2021
Q4 | $155 | Hold |
1,200
| – | – | ﹤0.01% | 320 |
|
|
2021
Q3 | $135 | Hold |
1,200
| – | – | ﹤0.01% | 318 |
|
|
2021
Q2 | $124 | Hold |
1,200
| – | – | ﹤0.01% | 323 |
|
|
2021
Q1 | $100 | Hold |
1,200
| – | – | ﹤0.01% | 328 |
|
|
2020
Q4 | $109 | Hold |
1,200
| – | – | ﹤0.01% | 285 |
|
|
2020
Q3 | $95 | Hold |
1,200
| – | – | ﹤0.01% | 302 |
|
|
2020
Q2 | $82 | Hold |
1,200
| – | – | ﹤0.01% | 296 |
|
|
2020
Q1 | $75 | Buy |
+1,200
| New | +$86.5K | ﹤0.01% | 296 |
|
|
2019
Q2 | $73 | Buy |
+1,200
| New | +$72.6K | ﹤0.01% | 278 |
|
|
2018
Q4 | $61.3K | Sell |
1,200
-129
| -10% | -$6.53K | 0.02% | 269 |
|
|
2018
Q3 | $14.2K | Sell |
1,329
-66
| -5% | -$3.23K | ﹤0.01% | 426 |
|
|
2018
Q2 | $68K | Hold |
1,395
| – | – | 0.02% | 267 |
|
|
2018
Q1 | $63K | Hold |
1,395
| – | – | 0.03% | 260 |
|
|
2017
Q4 | $54.9K | Hold |
1,395
| – | – | 0.03% | 272 |
|
|
2017
Q3 | $51.3K | Buy |
1,395
+66
| +5% | +$2.52K | 0.03% | 266 |
|
|
2017
Q2 | $52.1K | Buy |
1,329
+129
| +11% | +$4.71K | 0.03% | 260 |
|
|
2017
Q1 | $37.2K | Hold |
1,200
| – | – | 0.02% | 281 |
|
|
2016
Q4 | $39.5K | Buy |
+1,200
| New | +$38.9K | 0.03% | 203 |
|
Other funds holding EW
Westside Investment Management's EW Position: Q2 2026 in Review
Westside Investment Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 702 shares worth $63.5K. The position accounts for 0.01% of the portfolio, ranked #525.
Westside Investment Management first reported a position in EW in Q4 2016 and has held it in 36 quarters since. The position peaked at $115K in Q1 2024. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Westside Investment Management held 702 shares of Edwards Lifesciences worth $63.5K as of Q2 2026.
- Westside Investment Management left its Edwards Lifesciences share count unchanged in Q2 2026.
- Edwards Lifesciences made up 0.01% of Westside Investment Management's portfolio in Q2 2026, its #525 holding.
- Westside Investment Management first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 36 quarters since.
- Westside Investment Management's Edwards Lifesciences position peaked at $115K in Q1 2024.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.